NO984058L - Quinoksalindioner - Google Patents

Quinoksalindioner

Info

Publication number
NO984058L
NO984058L NO984058A NO984058A NO984058L NO 984058 L NO984058 L NO 984058L NO 984058 A NO984058 A NO 984058A NO 984058 A NO984058 A NO 984058A NO 984058 L NO984058 L NO 984058L
Authority
NO
Norway
Prior art keywords
quinoksalindioner
Prior art date
Application number
NO984058A
Other languages
English (en)
Norwegian (no)
Other versions
NO984058D0 (no
Inventor
David John Bull
Christopher Lee Carr
Michael Jonathan Fray
Elisabeth Colette Loui Gautier
Charles Eric Mowbray
Alan Stobie
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of NO984058D0 publication Critical patent/NO984058D0/no
Publication of NO984058L publication Critical patent/NO984058L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO984058A 1996-03-09 1998-09-03 Quinoksalindioner NO984058L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9605027.3A GB9605027D0 (en) 1996-03-09 1996-03-09 Quinoxalinediones
PCT/EP1997/000995 WO1997032873A1 (en) 1996-03-09 1997-02-27 Quinoxalinediones

Publications (2)

Publication Number Publication Date
NO984058D0 NO984058D0 (no) 1998-09-03
NO984058L true NO984058L (no) 1998-11-06

Family

ID=10790134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984058A NO984058L (no) 1996-03-09 1998-09-03 Quinoksalindioner

Country Status (42)

Country Link
US (1) US6376490B1 (de)
EP (1) EP0885212B1 (de)
JP (1) JP3110467B2 (de)
KR (1) KR100288099B1 (de)
CN (1) CN1103770C (de)
AP (1) AP767A (de)
AR (1) AR006119A1 (de)
AT (1) ATE208773T1 (de)
AU (1) AU717972B2 (de)
BG (1) BG63340B1 (de)
BR (1) BR9707851A (de)
CA (1) CA2248366C (de)
CO (1) CO4770976A1 (de)
CZ (1) CZ292792B6 (de)
DE (1) DE69708269T2 (de)
DK (1) DK0885212T3 (de)
DZ (1) DZ2188A1 (de)
EA (1) EA001730B1 (de)
ES (1) ES2163742T3 (de)
GB (1) GB9605027D0 (de)
HN (1) HN1998000034A (de)
HR (1) HRP970132A2 (de)
HU (1) HUP9900975A3 (de)
ID (1) ID18112A (de)
IL (1) IL125491A (de)
IS (1) IS4811A (de)
MA (1) MA26422A1 (de)
NO (1) NO984058L (de)
NZ (1) NZ331060A (de)
OA (1) OA10850A (de)
PE (2) PE43398A1 (de)
PL (1) PL329032A1 (de)
PT (1) PT885212E (de)
SI (1) SI0885212T1 (de)
SK (1) SK283467B6 (de)
TN (1) TNSN97044A1 (de)
TR (1) TR199801782T2 (de)
TW (1) TW454004B (de)
UY (1) UY24482A1 (de)
WO (1) WO1997032873A1 (de)
YU (2) YU39698A (de)
ZA (1) ZA971987B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK113399A3 (en) * 1997-02-27 2001-04-09 Pfizer Quinoxalinediones
AP982A (en) * 1997-02-27 2001-07-16 Pfizer Quinoxalinediones.
US6340758B1 (en) * 1997-05-16 2002-01-22 Warner-Lambert Company Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents
DE10005150A1 (de) * 2000-02-07 2001-08-09 Merck Patent Gmbh Verfahren zur Herstellung von 5-Arylnicotinaldehyden
EP1293503A4 (de) * 2000-05-19 2008-04-02 Astellas Pharma Inc Triazol-derivate
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
WO2005006945A2 (en) * 2003-07-03 2005-01-27 The Salk Institute For Biological Studies Methods for treating neural disorders and compounds useful therefor
MY145368A (en) 2004-01-13 2012-01-31 Nissan Chemical Ind Ltd Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
WO2005076295A1 (ja) 2004-02-06 2005-08-18 Yamaguchi University エネルギー貯蔵デバイス用電極及びその製造方法
JP2007223901A (ja) * 2004-03-24 2007-09-06 Takeda Chem Ind Ltd 複素環化合物およびその用途
US20060211739A1 (en) * 2005-02-08 2006-09-21 Arturo Perez-Medrano Use of selective P2X7 receptor antagonists
WO2007112347A1 (en) * 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP2089383B1 (de) 2006-11-09 2015-09-16 Probiodrug AG 3-hydroxy-1,5-dihydropyrrol-2-one derivate als inhibitoren von glutaminylcyclase zur behandlung von geschwüren, krebs und anderen krankheiten
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8603980B2 (en) 2007-01-16 2013-12-10 The Johns Hopkins University Glutamate receptor antagonists and methods of use
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
CN106928157A (zh) 2007-05-17 2017-07-07 株式会社半导体能源研究所 三唑衍生物
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (de) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazolderivate als glutaminylcyclase-hemmer
CA2900300A1 (en) * 2013-02-07 2014-08-14 Merck Patent Gmbh Substituted acetylene derivatives and their use as positive allosteric modulators of mglur4
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
CN111548320B (zh) * 2019-10-09 2023-03-24 贵州大学 一类1,3,4-噁二唑酰肼类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194985T1 (de) * 1990-11-06 2000-08-15 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
DE4217952A1 (de) * 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
SK113399A3 (en) * 1997-02-27 2001-04-09 Pfizer Quinoxalinediones

Also Published As

Publication number Publication date
UY24482A1 (es) 2000-09-29
HRP970132A2 (en) 1998-06-30
GB9605027D0 (en) 1996-05-08
IS4811A (is) 1998-07-27
DZ2188A1 (fr) 2002-12-02
NZ331060A (en) 2000-01-28
US6376490B1 (en) 2002-04-23
CZ292792B6 (cs) 2003-12-17
ID18112A (id) 1998-03-05
IL125491A0 (en) 1999-03-12
CA2248366C (en) 2002-06-04
NO984058D0 (no) 1998-09-03
AR006119A1 (es) 1999-08-11
AP9700947A0 (en) 1997-04-30
ATE208773T1 (de) 2001-11-15
DK0885212T3 (da) 2002-03-25
WO1997032873A1 (en) 1997-09-12
PE43398A1 (es) 1998-08-29
PL329032A1 (en) 1999-03-01
MA26422A1 (fr) 2004-12-20
BG63340B1 (bg) 2001-10-31
CN1103770C (zh) 2003-03-26
SK121498A3 (en) 2000-10-09
AU717972B2 (en) 2000-04-06
KR100288099B1 (ko) 2001-05-02
EA199800702A1 (ru) 1999-04-29
DE69708269D1 (de) 2001-12-20
YU39698A (sh) 1999-03-04
BR9707851A (pt) 1999-07-27
HUP9900975A2 (hu) 1999-07-28
JPH11506123A (ja) 1999-06-02
HN1998000034A (es) 1999-02-09
SI0885212T1 (en) 2002-02-28
EP0885212B1 (de) 2001-11-14
IL125491A (en) 2003-07-06
PE58199A1 (es) 1999-06-11
AU2023197A (en) 1997-09-22
AP767A (en) 1999-09-29
YU41199A (sh) 2001-09-28
CA2248366A1 (en) 1997-09-12
TNSN97044A1 (fr) 2005-03-15
BG102760A (en) 1999-09-30
ES2163742T3 (es) 2002-02-01
CZ286498A3 (cs) 1999-07-14
HUP9900975A3 (en) 2001-12-28
CN1213369A (zh) 1999-04-07
TW454004B (en) 2001-09-11
EP0885212A1 (de) 1998-12-23
PT885212E (pt) 2002-02-28
SK283467B6 (sk) 2003-08-05
EA001730B1 (ru) 2001-08-27
KR19990087614A (ko) 1999-12-27
OA10850A (en) 2001-08-16
TR199801782T2 (xx) 1998-12-21
DE69708269T2 (de) 2002-07-25
CO4770976A1 (es) 1999-04-30
JP3110467B2 (ja) 2000-11-20
ZA971987B (en) 1998-09-07

Similar Documents

Publication Publication Date Title
BR9703884A (pt) Cicloalcanopiridinas
BR9704464A (pt) Evisceradora
ATE262512T1 (de) Arylalkanoylpyridazine
DE69708269D1 (de) Chinoxalindione
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
DE59609702D1 (de) Pulversprüheinrichtung
BR9703563A (pt) Hidromancal
BR9707467A (pt) 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas
BR9703835A (pt) Hidromancal
DE59706319D1 (de) Carbamoylcarbonsäureamidoxime
BR9708716A (pt) 3-cianoaril-pirazóis
ATE267568T1 (de) Epithese
DE59610630D1 (de) Paradontalsonde
BR9600914A (pt) Lipodecantador
BR9603977A (pt) Fix-ped
BR7603088U (pt) Kitgeométrico
BR9604349A (pt) Xapisqueira
BR7603147U (pt) Simborgueup
BR7603380U (pt) Abratporta
BR7603492U (pt) Protemilk
BR9600112A (pt) Conaço
BR7601926U (pt) Sofá-mesa
BR9600920A (pt) Otimizador-turbinado-nb
BR9601152A (pt) Drenovaporvia
BR9602174A (pt) Lecton massoterapeutico